Table 4.
Biomarker | OR (95% CI) |
---|---|
P16 loss | 0.25 (0.09–0.75) |
P53 loss | 0.45 (0.16–1.32) |
C-MYC gain | 1.07 (0.44–2.56) |
HER2-NEU gain | 0.60 (0.03–44.00) |
20 q gain | 0.50 (0.01–37.49) |
Multiple gains | 0.15 (0.01–3.72) |
OR for each biomarker adjusted for the following clinical variables: age, sex, Barrett’s segment length, PDT, and EMR.